Low Risk is the New High Risk: Implications of National Policy on Occupational Exposure to Blood and Body Fluids in US Hospitals
This study measures the implications of the NSPA and its incorporation into the OSHA BPS by determining whether the comparison of MSSIs to PCSIs varied over three study periods; 1995-1999 (prior to NSPA), 2000-2002 (NSPA and OSHA promulgation), and afterwards in 2003-2007; comparing those in high risk to low risk hospital areas.
This study is the largest of its kind, analyzing over 30,000 exposure incidents from nearly 70 U.S. hospitals reporting into the Exposure Prevention Information Network (EPINet™*) were analyzed. Preliminary analysis of MSSI:PCSI was compared for each time period for high risk and low risk hospital areas. Additionally, PPE use was analyzed for all MSSIs across the study period. Appropriate incident-specific PPE use was compared, meaning when eye incidents were identified, so was use of eye-appropriate PPE (e.g., eyeglasses, side shields, faceshields or goggles).
The results of this study will be shared, as well as its potential implication for assessing the impact of national policy on occupational exposures and OAIs in healthcare.
Learning Areas:Occupational health and safety
Protection of the public in relation to communicable diseases including prevention or control
Provision of health care to the public
Public health or related public policy
Describe current state of risks associated with blood and body fluid exposures in US hospitals Differentiate and evaluate risk comparing needlesticks (percutaneous) and splashes and splatters (mucotaneous) Evaluate impact of federal law (Needlestick Safety and Prevention Act) on federal regulations (OSHA Bloodborne Pathogens Standard) Compare PPE use and appropriateness of PPE use in high risk compared to low risk hospital departments
Keyword(s): Occupational Health and Safety, Pathogens
Qualified on the content I am responsible for because: I am the researcher who conducted the study.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.